Uncategorized

Uncategorized

New Releases from NCBI BookshelfCommunity Support, Partnerships, and Inclusive Environments for Black Students and Professionals in Science, Engineering, and Medicine: Proceedings of a Workshop.​Community Support, Partnerships, and Inclusive Environments for Black Students and Professionals in Science, Engineering, and Medicine: Proceedings of a Workshop.

Individuals, institutions, and communities all have a role in strengthening representation of Black men and Black women in science, engineering,

Uncategorized

New Releases from NCBI BookshelfAvatrombopag (Doptelet): CADTH Reimbursement Recommendation: Indication: For the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment [Internet].​Avatrombopag (Doptelet): CADTH Reimbursement Recommendation: Indication: For the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment [Internet].

We recommend that Doptelet not be reimbursed by public drug plans for the treatment of thrombocytopenia in adults with chronic

Uncategorized

New Releases from NCBI BookshelfTralokinumab (Adtralza): CADTH Reimbursement Recommendation: Indication: For the treatment of moderate-to-severe atopic dermatitis in adult and adolescent patients 12 years and older whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. Tralokinumab can be used with or without topical corticosteroids [Internet].​Tralokinumab (Adtralza): CADTH Reimbursement Recommendation: Indication: For the treatment of moderate-to-severe atopic dermatitis in adult and adolescent patients 12 years and older whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. Tralokinumab can be used with or without topical corticosteroids [Internet].

CADTH recommends that Adtralza should not be reimbursed by public drug plans for the treatment of moderate to severe atopic

Uncategorized

New Releases from NCBI BookshelfInclisiran (Leqvio): CADTH Reimbursement Recommendation: Indication: For use as an adjunct to lifestyle changes, including diet, to further reduce low-density lipoprotein cholesterol (LDL-C) level in adults with non-familial hypercholesterolemia with atherosclerotic cardiovascular disease who are on maximally tolerated dose of a statin, with or without other LDL-C-lowering therapies [Internet].​Inclisiran (Leqvio): CADTH Reimbursement Recommendation: Indication: For use as an adjunct to lifestyle changes, including diet, to further reduce low-density lipoprotein cholesterol (LDL-C) level in adults with non-familial hypercholesterolemia with atherosclerotic cardiovascular disease who are on maximally tolerated dose of a statin, with or without other LDL-C-lowering therapies [Internet].

CADTH recommends that Leqvio not be reimbursed by public drug plans as an adjunct to lifestyle changes, including diet, to

Uncategorized

New Releases from NCBI BookshelfCannabidiol (Epidiolex): CADTH Reimbursement Recommendation: Indication: Use as adjunctive therapy for the treatment of seizures associated with Dravet Syndrome in patients 2 years of age and older [Internet].​Cannabidiol (Epidiolex): CADTH Reimbursement Recommendation: Indication: Use as adjunctive therapy for the treatment of seizures associated with Dravet Syndrome in patients 2 years of age and older [Internet].

CADTH recommends that Epidiolex be reimbursed by public drug plans for the adjunctive therapy of seizures associated with Dravet syndrome

Scroll to Top